OFM
TARA icon

Omega Fund Management’s Protara Therapeutics TARA Stock Holding History

Omega Fund Management’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-6,250
Closed -$1.98M – 12
2016
Q3 		$2.33M Hold
6,250
– – 1.78% 8
2016
Q2 		$2.01M Hold
6,250
– – 1.49% 9
2016
Q1 		$1.94M Hold
6,250
– – 1.34% 9
2015
Q4 		$3.88M Hold
6,250
– – 2.16% 8
2015
Q3 		$3.48M Hold
6,250
– – 1.96% 8
2015
Q2 		$4.46M Hold
6,250
– – 2.25% 5
2015
Q1 		$2.91M Hold
6,250
– – 1.26% 7
2014
Q4 		$2.6M Buy
+6,250
New +$2.52M 1.2% 7

Other funds holding TARA

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
FCI
Financial Counselors Inc Overland Park, Kansas $70.9M AUM 16.78% 1-Year Est. Return

Omega Fund Management's TARA Position: Q4 2016 in Review

Omega Fund Management sold out of Protara Therapeutics (TARA) in Q4 2016, closing a stake of 6,250 shares — an estimated $1.98M sold.

Omega Fund Management first reported a position in TARA in Q4 2014 and held it in 8 quarters. The position peaked at $4.46M in Q2 2015. 25 funds tracked by Wall St. Rank hold TARA as of Q4 2016.

  • Omega Fund Management reported no remaining Protara Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Omega Fund Management sold 6,250 Protara Therapeutics shares in Q4 2016, an estimated $1.98M.
  • Omega Fund Management first reported a position in Protara Therapeutics in Q4 2014 and held it in 8 quarters.
  • Omega Fund Management's Protara Therapeutics position peaked at $4.46M in Q2 2015.
  • 25 funds tracked by Wall St. Rank held Protara Therapeutics as of Q4 2016.

Based on Omega Fund Management's 13F filing for Q4 2016, filed 10 Feb 2017.